![Sharon Mates](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sharon Mates
Direktor/Vorstandsmitglied bei
MEDINCELL S.A.
Profil
Sharon L.
Mates is the founder of ITI, Inc. (New York), founded in 2002, serving as Chairman, President & Chief Executive Officer since 2002.
Dr. Mates was the founder of Intra-Cellular Therapies, Inc., founded in 2013, and held the titles of Chairman, President & Chief Executive Officer in 2013 and Chairman & Chief Executive Officer from 2024 to 2025.
Dr. Mates was the founder of Functional Genetics, Inc., founded in 2000, serving as Chairman & Chief Executive Officer from 2000 to 2003.
Current jobs include Director at PureTech Health Plc starting in 2026, Director-Emerging Company Section at Biotechnology Innovation Organization, Independent Director at MedinCell SA starting in 2025, Independent Director at Benitec Biopharma, Inc. starting in 2025, and Advisor at The New York City Investment Fund Manager, Inc. Former jobs include Chairman at New York Biotechnology Association, Inc., President & Director at North American Vaccine, Inc. from 1989 to 1998, Director-Biotechnology Institute at the University of Maryland, and Director at Gilda's Club New York City, Inc. Education includes a doctorate from the University of Washington conferred in 1981 and undergraduate studies at The Ohio State University.
Aktive Positionen von Sharon Mates
| Unternehmen | Position | Beginn |
|---|---|---|
| MEDINCELL S.A. | Direktor/Vorstandsmitglied | 11.09.2025 |
| BENITEC BIOPHARMA INC. | Direktor/Vorstandsmitglied | 03.11.2025 |
| PURETECH HEALTH PLC | Direktor/Vorstandsmitglied | 27.04.2026 |
ITI, Inc. (New York) | Vorstandsvorsitzender | 01.06.2002 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Corporate Officer/Principal | - |
The New York City Investment Fund Manager, Inc.
 The New York City Investment Fund Manager, Inc. Investment ManagersFinance The New York City Investment Fund Manager invests in the companies located in the United States. The firm focuses on fintech, health IT, life sciences and advanced manufacturing sectors. It participates in early and growth stage capital transactions. The firm acquires minority interest. | Berater | - |
Ehemalige bekannte Positionen von Sharon Mates
| Unternehmen | Position | Ende |
|---|---|---|
Intra-Cellular Therapies, Inc. /Old/
 Intra-Cellular Therapies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of neuropsychiatric and neurologic diseases | Vorstandsvorsitzender | 26.09.2013 |
Functional Genetics, Inc.
 Functional Genetics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Vorstandsvorsitzender | 01.08.2003 |
North American Vaccine, Inc.
 North American Vaccine, Inc. Pharmaceuticals: OtherHealth Technology Develops and sells vaccines for the prevention of infectious diseases | Präsident | 01.01.1998 |
| ░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Sharon Mates
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
61
Beziehungen ersten Grades
15
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
North American Vaccine, Inc.
North American Vaccine, Inc. Pharmaceuticals: OtherHealth Technology Develops and sells vaccines for the prevention of infectious diseases | Health Technology |
Intra-Cellular Therapies, Inc. /Old/
Intra-Cellular Therapies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of neuropsychiatric and neurologic diseases | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The New York City Investment Fund Manager, Inc.
The New York City Investment Fund Manager, Inc. Investment ManagersFinance The New York City Investment Fund Manager invests in the companies located in the United States. The firm focuses on fintech, health IT, life sciences and advanced manufacturing sectors. It participates in early and growth stage capital transactions. The firm acquires minority interest. | Finance |
New York Biotechnology Association, Inc.
 New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an association that promotes the biotechnology industry | Commercial Services |
Functional Genetics, Inc.
Functional Genetics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Gilda's Club New York City, Inc.
 Gilda's Club New York City, Inc. Miscellaneous Commercial ServicesCommercial Services Provides support services to cancer patients | Commercial Services |
MedinCell SA
 MedinCell SA Pharmaceuticals: MajorHealth Technology Provides therapeutic solutions | Health Technology |
Intra-Cellular Therapies, Inc.
 Intra-Cellular Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes small molecule drugs to treat neuropsychiatric and neurological disorders | Health Technology |
ITI, Inc. (New York) | |
PureTech Health Plc
 PureTech Health Plc BiotechnologyHealth Technology Engages in the development of treatment programs for obesity, cognitive disorders, baldness, depression, allergy and autoimmune | Health Technology |
Benitec Biopharma, Inc.
 Benitec Biopharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company and develops proprietary therapeutic technology platform | Health Technology |
